- Tweet
- Share this
- Email
- Print

Products made by Johnson & Johnson are displayed for sale on a store shelf in Westminster, Colorado April 14, 2009.
Credit: Reuters/Rick Wilking
Tue Apr 17, 2012 8:13am EDT
(Reuters) - Johnson & Johnson (JNJ.N) reported better-than-expected quarterly earnings but global company revenue fell slightly on anemic sales of medical devices and consumer medicines -- businesses that have been hit by costly recalls in the past two years.
The diversified healthcare company said it earned $3.91 billion, or $1.41 per share, in the first quarter. That compared with $3.48 billion, or $1.25 per share, in the year-ago period.
Excluding special items, J&J earned $1.37 per share, topping the average analyst forecast of $1.35 per share, compiled by Thomson Reuters I/B/E/S.
Global company revenue slipped 0.2 percent to $16.14 billion, versus Wall Street expectations of $16.26 billion.
(Reporting By Ransdell Pierson; Editing by Maureen Bavdek)
Related Quotes and News
Company
Price
Related News
- Tweet this
- Link this
- Share this
- Digg this
- Email
- Reprints
Comments (0)
Be the first to comment on reuters.com.
Add yours using the box above.
0 comments:
Post a Comment